Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 2714149)

Published in Dig Dis Sci on May 01, 1989

Authors

C A Baum1, W L Biddle, P B Miner

Author Affiliations

1: Division of Gastroenterology, University of Kansas Medical Center, Kansas City 66103.

Articles by these authors

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study. Aliment Pharmacol Ther (2011) 2.02

Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci (1993) 1.83

Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects. Aliment Pharmacol Ther (2004) 1.41

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther (2000) 1.15

Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther (1998) 1.14

Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol (1999) 1.05

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology (1999) 1.05

Relation between rectal sensation and anal function in normal subjects and patients with faecal incontinence. Gut (1990) 1.02

Long-term use of mesalamine enemas to induce remission in ulcerative colitis. Gastroenterology (1990) 1.01

Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci (1992) 0.98

Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol (1997) 0.97

A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. Aliment Pharmacol Ther (2006) 0.97

Delayed rectal sensation with fecal incontinence. Successful treatment using anorectal manometry. Gastroenterology (1986) 0.95

The role of transient internal sphincter relaxation in faecal incontinence? Int J Colorectal Dis (1990) 0.93

Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard. Biochem Pharmacol (1979) 0.91

Exacerbation of chronic ulcerative colitis with mesalamine. Gastroenterology (1995) 0.90

Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 0.88

Exacerbation of ulcerative colitis. Gastroenterology (1991) 0.87

The effects of capsaicin on reflux, gastric emptying and dyspepsia. Aliment Pharmacol Ther (2000) 0.87

Pancreatitis and gold treatment of rheumatoid arthritis. Ann Intern Med (1989) 0.86

Regulation of hepatic sodium plus potassium-activated adenossine triphosphatase activity by glucocorticoids in the rat. Gastroenterology (1980) 0.85

Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis. Dig Dis Sci (1989) 0.84

Review article: refractory distal colitis -- explanations and options. Aliment Pharmacol Ther (1996) 0.83

Subjective, laryngoscopic, and acoustic measurements of laryngeal reflux before and after treatment with omeprazole. J Voice (1996) 0.82

Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn. Aliment Pharmacol Ther (2002) 0.81

The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. Aliment Pharmacol Ther (2003) 0.81

Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor. Aliment Pharmacol Ther (2003) 0.81

New therapeutic agents in the treatment of inflammatory bowel disease. Am J Med (1992) 0.81

5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology (1988) 0.80

Evaluation of anorectal physiology in patients with increased mast cells. Dig Dis Sci (1993) 0.80

Clinical effectiveness of a new antacid chewing gum on heartburn and oesophageal pH control. Aliment Pharmacol Ther (2002) 0.79

Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Aliment Pharmacol Ther (2004) 0.79

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn. Aliment Pharmacol Ther (2004) 0.79

The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings. Aliment Pharmacol Ther (2006) 0.79

Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas. Dig Dis Sci (1987) 0.78

The fractal nature of human gastro-oesophageal reflux. Aliment Pharmacol Ther (2005) 0.78

Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2002) 0.78

Laryngeal manifestations of gastroesophageal reflux disease: endoscopic appearance and management. Gastrointest Endosc (1996) 0.77

Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults. Aliment Pharmacol Ther (2007) 0.77

Intermittent gastric outlet obstruction from a pedunculated gastric polyp. Gastrointest Endosc (1982) 0.77

The effect of ethanol on hepatic sodium plus potassium activated adenosine triphosphatase activity in the rat. Gastroenterology (1981) 0.77

Evaluation of antral mast cells in nonulcer dyspepsia. Dig Dis Sci (1990) 0.77

Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole. Aliment Pharmacol Ther (2006) 0.77

Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn. Aliment Pharmacol Ther (2001) 0.76

Gastric mucosal nodules due to cytomegalovirus infection. Dig Dis Sci (1989) 0.76

Spironolactone- and canrenone-induced changes in hepatic (Na+,K+)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat. Hepatology (1983) 0.76

Seronegative juvenile rheumatoid arthritis and mast cell-associated gastritis. Arthritis Rheum (1991) 0.76

Effect of naproxen on gastric acid secretion and gastric pH. Aliment Pharmacol Ther (2006) 0.76

Conventional drug therapy in inflammatory bowel disease. Gastroenterol Clin North Am (1995) 0.76

Is maintenance therapy effective in Crohn's disease? Lancet (1994) 0.75

Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.75

Pheasant-induced dysphagia. Dig Dis Sci (2000) 0.75

Evaluation of antibiotic-associated diarrhea with a latex agglutination test and cell culture cytotoxicity assay for Clostridium difficile. Am J Gastroenterol (1989) 0.75

Characteristics of conjugated bile salt absorption by hamster jejunum. Biochim Biophys Acta (1971) 0.75

Upper gastrointestinal bleeding: a common medical emergency. J Kans Med Soc (1980) 0.75

Profuse diarrhea induced by Campylobacter. South Med J (1983) 0.75

Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor. Aliment Pharmacol Ther (2003) 0.75

Modern treatment of ulcerative colitis. Compr Ther (1989) 0.75

Value of radiopaque markers in identifying partial small bowel obstruction. Gastroenterology (1996) 0.75

A plastic head cover to reduce surgical heat loss. Geriatr Nurs (1985) 0.75